Literature DB >> 879327

Effect of hematocrit variations on coronary hemodynamics and oxygen utilization.

K M Jan, S Chien.   

Abstract

Twenty-five closed-chest pentobarbitalized dogs were used for studying coronary flow dynamics and myocardial oxygen utilization following variations of hematocrit (Hct) by isovolumetric exchange of blood with plasma or packed red cells. Coronary blood flow (133Xe washout) and cardiac output varied inversely with Hct. Coronary systemic, and pulmonary flow resistances varied in the same direction with Hct. Blood viscosity played a significant role in determining the flow resistances in these three regions. Analysis of vascular hindrance (vascular resistance/blood viscosity) suggested that coronary vasodilation occurred following Hct changes beyond the range of 20-60%. In systemic and pulmonary circulations, however, there was vasoconstriction following hemodilution. The range of optimum Hct for maximum O2 transport (blood flow X arterial O2 content) was much wider in coronary (20-60% Hct) than in systemic circulation (40-60% Hct). The O2 consumptions in total body and in myocardium were essentially constant over a wide range of Hct (20-60%). The maintenance of total body O2 consumption over the Hct range of 20-40% was attributable to an increase in A-V O2 extraction. The O2 extraction ratio in the coronary circulation was constant over the entire range of Hct studied, suggesting that the myocardial O2 consumption was primarily determined by the coronary O2 transport.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879327     DOI: 10.1152/ajpheart.1977.233.1.H106

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Optimal hematocrit based on regional cerebral blood flow in hemodialysis patients with diabetic nephropathy.

Authors:  Tsuneyoshi Oh; Osamu Sakayori; Chisako Kamano; Yuichi Komaba; Yasuhiko Iino; Yasuo Katayama
Journal:  Clin Exp Nephrol       Date:  2002-09       Impact factor: 2.801

Review 2.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Authors:  Jon A Detterich; Roberta M Kato; Miklos Rabai; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

Review 4.  Acceptable hematocrit levels in surgical patients.

Authors:  K F Messmer
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 5.  Transfusion Decision Making in Pediatric Critical Illness.

Authors:  Chris Markham; Sara Small; Peter Hovmand; Allan Doctor
Journal:  Pediatr Clin North Am       Date:  2017-10       Impact factor: 3.278

6.  Determinants of hemoglobin concentration in cyanotic heart disease.

Authors:  S S Gidding; M Bessel; Y L Liao
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

Review 7.  Intraoperative fluid therapy.

Authors:  L Thorén; L Wiklund
Journal:  World J Surg       Date:  1983-09       Impact factor: 3.352

8.  Hemodynamic interactions of hemodilution, anaesthesia, propranolol pretreatment and hypovolaemia. II: Coronary circulation.

Authors:  J Tarnow; H J Eberlein; W Hess; E Schneider; E Schweichel; G Zimmermann
Journal:  Basic Res Cardiol       Date:  1979 Mar-Apr       Impact factor: 17.165

Review 9.  Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach.

Authors:  Burak Zeybek; Andrew M Childress; Gokhan S Kilic; John Y Phelps; Luis D Pacheco; Michele A Carter; Mostafa A Borahay
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

10.  Current guidelines for blood conservation in cardiac surgery.

Authors:  Yatin Mehta; Jeetendra Sharma
Journal:  Indian J Anaesth       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.